Ipca Laboratories Ltd.

Financial

	Ipca Laboratories	Glaxosmithkline Phar	Glenmark Pharma
Operational Metrics
API Sector
US DMF Filings	55.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	43.0 .	n/a	13.0 .
Number of ANDA's Approved By USFDA	21.0 .	n/a	25.0 .
Domestic Sales Growth - YoY	6.3 %	3.1 %	12.7 %
R&D as a % of Total Sales	2.64 %	0.07 %	6.6 %
Financials
5 yr Average ROE	14.77 %	32.25 %	4.18 %
5yr average Equity Multiplier	1.47	1.83	1.88
5yr Average Asset Turnover Ratio	0.79	0.96	0.79
5yr Avg Net Profit Margin	12.85 %	20.54 %	2.73 %
Price to Book	5.99	22.94	5.13
P/E	60.71	56.85	0.0
5yr Avg Cash Conversion Cycle	62.7 Days	-70.08 Days	-121.67 Days
Inventory Days	101.09 Days	55.11 Days	40.44 Days
Days Receivable	63.37 Days	21.9 Days	36.38 Days
Days Payable	112.44 Days	130.75 Days	201.37 Days
5yr Average Interest Coverage Ratio	55.69	297.48	3.48
5yr Avg ROCE	18.16 %	38.79 %	16.29 %
5yr Avg Operating Profit Margin	19.9 %	23.02 %	15.62 %
5 yr average Debt to Equity	0.16	0.0	0.49
5yr CAGR Net Profit	-2.03 %	44.64 %	n/a
5yr Average Return on Assets	10.46 %	17.78 %	1.86 %
Shareholdings
Promoter Holding	46.3 %	75.0 %	46.65 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.01 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	6.73 %	0.92 %	6.77 %

Business

	Ipca Laboratories	Glaxosmithkline Phar	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 49.34 Formulations 31.07 Active Pharmaceutical Ingredient (API) 19.59 Vaccines 0 Pharmaceuticals 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Glenmark generics 0 Vaccines 24.0 Pharmaceutical 76.0 Branded Generics 0 Glenmark Pharma (Branded generics) 0 Active Pharmaceutical Ingredient (API) 0 Formulations 0	Product Wise Break-Up Formulations 39.54 Vaccines 0 Pharmaceuticals 0 Branded Generics 0 Branded Generics 60.46 Active Pharmaceutical Ingredient (API) 0 Formulations 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 52.0 Cardiac Science 17.0 Dermatology 6.0 Anti-bacterial 6.0 Urology 4.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Respiratory 0 Hormones 0 Pain/Analgesics 0 Vaccines 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Others 2.0	Therapeutic Area Wise Break-Up - Domestic Cough and colds 0 Cardiac Science 0 Pain Management 11.96 Anti-bacterial 0 Anti-Infective 22.25 Pain 0 Neutraceuticals 0 Vitamins / Minerals / Nutrients 6.47 Vaccines 12.64 0 Hormones 8.91 Gastro Intestinal 0 Urology 0 Dermatology 30.55 Respiratory 3.95 Anti Malarials 0 Central Nervous System (CNS) 0 Others 3.27	-
Location Wise Break-Up	Location Wise Break-Up India 46.34 USA 17.83 Europe 15.39 Africa 6.96 Asia Pacific 6.08 Australia 4.05 CIS 3.35 Rest of the World 0 Latin America 0 North America 0	Location Wise Break-Up Latin America 0 Asia Pacific 0 North America 0 CIS 0 Europe 0 USA 0 Rest of the World 1.78 Africa 0 India 98.22 Australia 0	Location Wise Break-Up Latin America 0 Asia Pacific 0 North America 22.0 CIS 0 Europe 20.0 USA 0 Rest of the World 20.0 Africa 0 India 37.0 Australia 0 Others 1.0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

SIGN UP FOR FREE